Cargando…

QTc prolongation and torsades de pointes due to a coadministration of fluoxetine and amiodarone in a patient with implantable cardioverter–defibrillator: Case report and review of the literature

RATIONALE: Drug-induced prolongation of the corrected QT interval (QTc) may lead to serious and potentially life-threatening ventricular tachyarrhythmia, such as torsades de pointes (Tdp), which is worthy of clinical attention. Here, we report 1 case of Tdp after a coadministration of fluoxetine and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Anhua, Peng, Jinlan, Gu, Zhichun, Li, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	4200
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728935/ https://www.ncbi.nlm.nih.gov/pubmed/29245320 http://dx.doi.org/10.1097/MD.0000000000009071

Ejemplares similares

Torsade de Pointes and Persistent QTc Prolongation after Intravenous Amiodarone
por: Kotsia, Anna P., et al.
Publicado: (2012)

Multiple drugs: QTc prolongation and torsades de pointes: case report
Publicado: (2021)

"Atrial torsades de pointes" Induced by Low-Energy Shock From Implantable-Cardioverter Defibrillator
por: Can, Ilknur, et al.
Publicado: (2013)

Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis
por: Lazzerini, Pietro Enea, et al.
Publicado: (2016)

Torsades de Pointes and Prolonged Self-Terminating Ventricular Fibrillation Induced by Amiodarone
por: Tziatzios, Georgios D, et al.
Publicado: (2020)

Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation
por: Nordkin, Irina, et al.
Publicado: (2020)

Amiodarone: Torsade de pointes: case report
Publicado: (2022)

QTc Prolongation in Patients Receiving Triazoles and Amiodarone
por: Cook, Katherine, et al.
Publicado: (2017)

Phenytoin in treatment of amiodarone-induced Torsades de pointes
por: Mukhopadhyay, Saibal, et al.
Publicado: (2012)

Correlation Between Donepezil and QTc Prolongation and Torsades de Pointes: A Very Rare Phenomenon
por: Malik, Bilal Haider, et al.
Publicado: (2019)

Multiple drugs: QTc prolongation leading to torsades-de-pointes and off-label use: case report
Publicado: (2021)

Incidence of drug-induced torsades de pointes with intravenous amiodarone
por: Shenthar, Jayaprakash, et al.
Publicado: (2017)

His Bundle Pacing in Amiodarone-Induced Complete Heart Block, QT Prolongation, and Torsade de Pointes
por: Tan, Vern Hsen, et al.
Publicado: (2020)

Ticagrelor-induced life-threatening bleeding via the cyclosporine-mediated drug interaction: A case report
por: Zhang, Chi, et al.
Publicado: (2017)

Azithromycin/hydroxychloroquine: QTc interval prolongation and torsades de pointes following off-label use: case report
Publicado: (2020)

Short‐term use of oral amiodarone causing torsades de pointes
por: Yau, Stephen, et al.
Publicado: (2018)

A Case of NAA10-related Syndrome With Prolonged QTc Treated With a Subcutaneous Implantable Cardioverter Defibrillator After Ventricular Fibrillation
por: Mizuno, Yuta, et al.
Publicado: (2022)

Survival after prolonged resuscitation with 99 defibrillations due to Torsade De Pointes cardiac electrical storm: a case report
por: Nakstad, Anders Rostrup, et al.
Publicado: (2010)

Anticancer drugs-related QTc prolongation, torsade de pointes and sudden death: current evidence and future research perspectives
por: Duan, Jialin, et al.
Publicado: (2018)

Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator—The PROLONG Study
por: Duncker, David, et al.
Publicado: (2017)

Mast cells activation and high blood tryptase levels due to paclitaxel administration. Is Cremophor EL the culprit?: A case report
por: D’Errico, Stefano, et al.
Publicado: (2020)

Implantable cardioverter-defibrillators /
Publicado: (1994)

DOTHIEPIN, QT PROLONGATION AND TORSADES DE POINTES
por: Andrade, Chittaranjan, et al.
Publicado: (1999)

Teratogenic Effects of Coadministration of Fluoxetine and Olanzapine on Rat Fetuses
por: Bakhtiarian, Azam, et al.
Publicado: (2014)

Coadministration of Atorvastatin and Amiodarone Increases the Risk of Pulmonary Fibrosis in Rats
por: Nasri, Hamid-Reza, et al.
Publicado: (2016)

Current port maintenance strategies are insufficient: View based on actual presentations of implanted ports
por: Chou, Pin-Li, et al.
Publicado: (2019)

QT prolongation and torsades de pointes with psychotropic agents
por: Desai, Nagaraj, et al.
Publicado: (2015)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Late presentation of Torsades de Pointes related to fluoxetine following a multiple drug overdose
por: Groot, Jan Albert Nicolaas, et al.
Publicado: (2018)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

Suppression of amiodarone‐induced torsade de pointes by landiolol in a patient with atrial fibrillation‐mediated cardiomyopathy
por: Takahashi, Koji, et al.
Publicado: (2021)

Torsade de Pointes Due to Hypokalemia and Hypomagnesemia
por: Cabahug, Mary Crista, et al.
Publicado: (2022)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Epicardial Cardioverter Defibrillator Implantation due to Post-Fontan Ventricular Tachycardia
por: Papakonstantinou, Nikolaos A, et al.
Publicado: (2020)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2dnmautejjqudt8d8rm5ljkokd